Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Vitamin C and cancer revisited.

Frei B, Lawson S.

Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11037-8. doi: 10.1073/pnas.0806433105. Epub 2008 Aug 5. No abstract available.

PMID:
18682554
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.

Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M.

Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9. doi: 10.1073/pnas.0804226105. Epub 2008 Aug 4.

PMID:
18678913
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Poly(ethylene glycol) anticancer drug delivery systems.

Greenwald RB.

P R Health Sci J. 2002 Jun;21(2):113-21. Review. No abstract available.

PMID:
12166021
[PubMed - indexed for MEDLINE]
4.

Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.

Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.

P R Health Sci J. 2004 Jun;23(2):115-8.

PMID:
15377059
[PubMed - indexed for MEDLINE]
5.

Prodrugs.

Backes WL.

Clin J Oncol Nurs. 2001 Jan-Feb;5(1):35. No abstract available.

PMID:
11899400
[PubMed - indexed for MEDLINE]
6.

Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.

Takakura Y, Hashida M.

Crit Rev Oncol Hematol. 1995 Mar;18(3):207-31. Review. No abstract available.

PMID:
7695833
[PubMed - indexed for MEDLINE]
7.

In vitro and in vivo models for evaluation of GDEPT: quantifying bystander killing in cell cultures and tumors.

Wilson WR, Pullen SM, Hogg A, Hobbs SM, Pruijn FB, Hicks KO.

Methods Mol Med. 2004;90:403-31. No abstract available.

PMID:
14657576
[PubMed - indexed for MEDLINE]
8.

Minicells overcome tumor drug-resistance.

Karagiannis ED, Anderson DG.

Nat Biotechnol. 2009 Jul;27(7):620-1. doi: 10.1038/nbt0709-620. No abstract available.

PMID:
19587665
[PubMed - indexed for MEDLINE]
9.

Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft models.

Friedlos F, Davies L, Scanlon I, Ogilvie LM, Martin J, Stribbling SM, Spooner RA, Niculescu-Duvaz I, Marais R, Springer CJ.

Cancer Res. 2002 Mar 15;62(6):1724-9.

PMID:
11912146
[PubMed - indexed for MEDLINE]
Free Article
10.

Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777.

Beauparlant P, Bédard D, Bernier C, Chan H, Gilbert K, Goulet D, Gratton MO, Lavoie M, Roulston A, Turcotte E, Watson M.

Anticancer Drugs. 2009 Jun;20(5):346-54. doi: 10.1097/CAD.0b013e3283287c20.

PMID:
19369827
[PubMed - indexed for MEDLINE]
11.

[Vitamin C in complementary oncology--update 2009].

Gröber U.

Med Monatsschr Pharm. 2009 Jul;32(7):263-7. Review. German.

PMID:
19731754
[PubMed - indexed for MEDLINE]
12.

Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.

Brusa P, Immordino ML, Rocco F, Cattel L.

Anticancer Res. 2007 Jan-Feb;27(1A):195-9.

PMID:
17352232
[PubMed - indexed for MEDLINE]
Free Article
13.

Antibody-directed enzyme prodrug therapy (ADEPT) for cancer.

Bagshawe KD, Sharma SK, Begent RH.

Expert Opin Biol Ther. 2004 Nov;4(11):1777-89. Review.

PMID:
15500406
[PubMed - indexed for MEDLINE]
14.

Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell.

Calderón M, Welker P, Licha K, Fichtner I, Graeser R, Haag R, Kratz F.

J Control Release. 2011 May 10;151(3):295-301. doi: 10.1016/j.jconrel.2011.01.017. Epub 2011 Jan 21.

PMID:
21256902
[PubMed - indexed for MEDLINE]
15.

Recent advances with monoclonal antibody drug targeting for the treatment of human cancer.

Koppel GA.

Bioconjug Chem. 1990 Jan-Feb;1(1):13-23. Review. No abstract available.

PMID:
2095201
[PubMed - indexed for MEDLINE]
16.

Anticancer drug delivery systems: N4-acyl poly(ethyleneglycol) prodrugs of ara-C. I. Efficacy in solid tumors.

Choe YH, Conover CD, Wu D, Royzen M, Greenwald RB.

J Control Release. 2002 Feb 19;79(1-3):41-53.

PMID:
11853917
[PubMed - indexed for MEDLINE]
17.

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.

PMID:
14522925
[PubMed - indexed for MEDLINE]
Free Article
18.

Synthesis and antitumor efficacy of a β-glucuronidase-responsive albumin-binding prodrug of doxorubicin.

Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Berjeaud JM, Guilhot F, Papot S.

J Med Chem. 2012 May 10;55(9):4516-20. doi: 10.1021/jm300348r. Epub 2012 Apr 30.

PMID:
22515366
[PubMed - indexed for MEDLINE]
19.

Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models.

Chen P, Stone J, Sullivan G, Drisko JA, Chen Q.

Free Radic Biol Med. 2011 Aug 1;51(3):681-7. doi: 10.1016/j.freeradbiomed.2011.05.031. Epub 2011 May 30.

PMID:
21672627
[PubMed - indexed for MEDLINE]
20.

The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.

Na YS, Jung KA, Kim SM, Hong YS, Ryu MH, Jang SJ, Moon DH, Cho DH, Kim JC, Lee JS, Kim TW.

Cancer Chemother Pharmacol. 2011 Aug;68(2):389-98. doi: 10.1007/s00280-010-1495-6. Epub 2010 Nov 3.

PMID:
21046105
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk